Yes-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 4, 2012, Pages 989-1001

  Cui, Z L ^a   Han, F F ^a   Peng, X H ^a   Chen, X ^a   Luan, C Y ^a   Han, R C ^a   Xu, Wei Guo ^a   Guo, Xue Jun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adenocarcinoma; Clinicopathology; Growth; Metastasis; Receptor tyrosine kinase; Yes associated protein 1

Indexed keywords

CYCLINE; GELATINASE B; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE AX1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN 1; MEMBRANE PROTEIN; RECEPTOR TYROSINE KINASE AXL;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR VOLUME; AGE DISTRIBUTION; CANCER CELL CULTURE; CANCER SIZE; CANCER THERAPY; CANCER TISSUE; CELL INVASION; GENE EXPRESSION; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; SEX DIFFERENCE; STOMACH ADENOCARCINOMA;

EID: 84872946587     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500416     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. Viktorsson K, Lewensohn R, Zhivotovsky B. Apoptotic pathways and therapy resistance in human malignancies. Adv Cancer Res 2005; 94:143-96.
3. William WN Jr, Glisson BS. Novel strategies for the treatment of small-cell lung carcinoma. Nat Rev Clin Oncol 2011; 8:611-9.
4. Tajima Y, Yamazaki K, Makino R, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006; 12:6469-79.
5. Oh H, Irvine KD. Yorkie: the final destination of Hippo signaling. Trends Cell Biol 2010; 20:410-7.
6. Zhao B, Wei X, Li W, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21:2747-61.
7. Overholtzer M, Zhang J, Smolen GA, et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 2006; 103:12405-10.
8. Guo J, Kleeff J, Zhao Y, et al. Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma. Int J Mol Med 2006; 17:761-7.
9. Steinhardt AA, Gayyed MF, Klein AP, et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008; 39:1582-9.
10. Xu MZ, Yao TJ, Lee NP, et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009; 115:4576-85.
11. Korshunov VA. Axl-dependent signalling: a clinical update. Clin Sci (Lond) 2012; 122:361-8.
12. Holland SJ, Powell MJ, Franci C, et al. Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res 2005; 65:9294-303.
13. Zhao B, Lei QY, Guan KL. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 2008; 20:638-46.
14. Hanahan D, Weinberg RA: The hallmarks of cancer: the next generation. Cell 2011; 144:646-74.
15. Orr BA, Bai H, Odia Y, et al. Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. J Neuropathol Exp Neurol 2011; 70:568-77.
16. Muramatsu T, Imoto I, Matsui T, et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 2011; 32:389-98.
17. Kang W, Tong JH, Chan AW, et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res 2011; 17:2130-9.
18. Sainaghi PP, Castello L, Bergamasco L, et al. Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor. J Cell Physiol 2005; 204:36-44.
19. Mc Cormack O, Chung WY, Fitzpatrick P, et al. Growth arrest-specific gene 6 expression in human breast cancer. Br J Cancer 2008; 98:1141-6.
20. van Ginkel PR, Gee RL, Shearer RL, et al. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res 2004; 64:128-34.
21. Hutterer M, Knyazev P, Abate A, et al. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res 2008; 14:130-8.
22. Xu MZ, Chan SW, Liu AM, et al. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 2011; 30:1229-40.
23. Czyzewska J, Guzińska-Ustymowicz K, Lebelt A, et al. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers. Rocz Akad Med Bialymst 2004; 49:64-6.
24. Ueda J, Kajita M, Suenaga N, Fujii K, Seiki M. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene 2003; 22:8716-22.
25. Temma T, Sano K, Kuge Y, Kamihashi J, Takai N, Ogawa Y, Saji H. Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors. Biol Pharm Bull 2009; 32: 1272-7.
26. Zhou Z, Zhu JS, Xu ZP, Zhang Q. Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line. Mol Med Report 2011; 4:1075-82.
27. Tai KY, Shieh YS, Lee CS, et al. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1. Oncogene 2008; 27:4044-55.